Chemoinformaics analysis of ICOSA-8,11,14-TRIENOIC ACID
Molecular Weight | 306.49 | nRot | 15 |
Heavy Atom Molecular Weight | 272.218 | nRig | 0 |
Exact Molecular Weight | 306.256 | nRing | 0 |
Solubility: LogS | -3.697 | nHRing | 0 |
Solubility: LogP | 2.141 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 57.675 |
nHD | 1 | BPOL | 34.977 |
QED | 0.451 |
Synth | 4.047 |
Natural Product Likeliness | 0.432 |
NR-PPAR-gamma | 0.01 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.006 |
CACO-2 | -4.303 |
MDCK | 0.0000241 |
BBB | 0.806 |
PPB | 0.594714 |
VDSS | 1.071 |
FU | 0.344108 |
CYP1A2-inh | 0.911 |
CYP1A2-sub | 0.95 |
CYP2c19-inh | 0.952 |
CYP2c19-sub | 0.896 |
CYP2c9-inh | 0.688 |
CYP2c9-sub | 0.82 |
CYP2d6-inh | 0.104 |
CYP2d6-sub | 0.873 |
CYP3a4-inh | 0.016 |
CYP3a4-sub | 0.263 |
CL | 11.547 |
T12 | 0.297 |
hERG | 0.109 |
Ames | 0.556 |
ROA | 0.766 |
SkinSen | 0.929 |
Carcinogencity | 0.488 |
EI | 0.995 |
Respiratory | 0.974 |
NR-Aromatase | 0.013 |
Antiviral | No |
Prediction | 0.551533 |